Patents by Inventor Quyen-Quyen Thuy Do

Quyen-Quyen Thuy Do has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20240156975
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: September 11, 2023
    Publication date: May 16, 2024
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • Compositions and methods for the treatment of viral infections
    Patent number: 11833213
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: December 5, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: James M. Balkovec, Daniel C. Bensen, Allen Borchardt, Thomas P. Brady, Zhi-Yong Chen, Jason Cole, Quyen-Quyen Thuy Do, Simon Doehrmann, Wanlong Jiang, Thanh Lam, Alain Noncovich, Leslie W. Tari
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20230190950
    Abstract: Compositions and methods for the treatment of bacterial infections include conjugates containing an Fc domain covalently linked to one or more monomers of cyclic heptapeptides or one or more dimers of cyclic heptapeptides. In particular, conjugates can be used in the treatment of bacterial infections caused by Gram-negative bacteria.
    Type: Application
    Filed: December 20, 2017
    Publication date: June 22, 2023
    Inventors: Suzanne AKERS-RODRIGUEZ, James Michael BALKOVEC, Daniel C. BENSEN, Timothy BLIZZARD, Allen BORCHARDT, Thomas Patrick BRADY, Zhi-Yong CHEN, Quyen-Quyen Thuy DO, Joanne M. FORTIER, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20230165970
    Abstract: Compositions and methods for the treatment of bacterial infections include conjugates containing an Fc domain covalently linked to one or more monomers of cyclic heptapeptides or one or more dimers of cyclic heptapeptides. In particular, conjugates can be used in the treatment of bacterial infections caused by Gram-negative bacteria.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 1, 2023
    Inventors: Suzanne AKERS-RODRIGUEZ, James M. BALKOVEC, Daniel C. BENSEN, Timothy BLIZZARD, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Joanne M. FORTIER, Wanlong JIANG, Thanh LAM, James LEVIN, Alain NONCOVICH, Leslie W. TARI
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS
    Publication number: 20230082611
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral RSV F protein (e.g., Presatovir, MDT 637, JNJ 179, or an analog thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., RSV infections).
    Type: Application
    Filed: June 12, 2020
    Publication date: March 16, 2023
    Inventors: Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Quyen-Quyen Thuy DO, Travis James HAUSSENER, Alain NONCOVICH, Leslie W. TARI
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
    Publication number: 20230079107
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral gp120 receptor (e.g., temsavir, BMS-818251, DMJ-ll-121, BNM-IV-147, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., HIV infections).
    Type: Application
    Filed: June 12, 2020
    Publication date: March 16, 2023
    Inventors: Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Quyen-Quyen Thuy DO, Wanlong JIANG, Leslie W. TARI
  • MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO
    Publication number: 20220396579
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor.
    Type: Application
    Filed: April 22, 2022
    Publication date: December 15, 2022
    Inventors: Thuy-Anh Tran, Brett Ullman, Bryan Aubrey Kramer, Quyen-Quyen Thuy Do, Young-Jun Shin
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20220257787
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: April 21, 2021
    Publication date: August 18, 2022
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto
    Patent number: 11339172
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of a beta-3 adrenergic receptor-mediated disorder, such as, heart failure and related disorders thereto.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: May 24, 2022
    Assignee: Arena Pharmaceuticals, Inc.
    Inventors: Thuy-Anh Tran, Brett Ullman, Bryan Aubrey Kramer, Quyen-Quyen Thuy Do, Young-Jun Shin
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20210228727
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: March 5, 2021
    Publication date: July 29, 2021
    Applicants: Cidara Therapeutics, Inc., Cidara Therapeutics, Inc.
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20210220478
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Applicant: Cidara Therapeutics, Inc.
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • MODULATORS OF THE BETA-3 ADRENERGIC RECEPTOR USEFUL FOR THE TREATMENT OR PREVENTION OF HEART FAILURE AND DISORDERS RELATED THERETO
    Publication number: 20200385395
    Abstract: The present invention relates to compounds of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the beta-3 adrenergic receptor.
    Type: Application
    Filed: December 6, 2018
    Publication date: December 10, 2020
    Inventors: Thuy-Anh Tran, Brett Ullman, Bryan Aubrey Kramer, Quyen-Quyen Thuy Do, Young-Jun Shin
  • Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
    Patent number: 6903132
    Abstract: Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: June 7, 2005
    Assignees: Agouron Pharmaceuticals, Inc., Pfizer Inc.
    Inventors: Mark B. Anderson, Lance Christopher Christie, Quyen-Quyen Thuy Do, Jun Feng, Yufeng Hong, Haitao Li, Ved P. Pathak, Ranjan Jagath Rajapakse, Eric T. Sun, Eileen Valenzuela Tompkins
  • Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
    Publication number: 20040014787
    Abstract: Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated. Methods for synthesizing the compounds and intermediates useful in their preparation are also described.
    Type: Application
    Filed: June 11, 2003
    Publication date: January 22, 2004
    Applicant: Agouron Pharmaceuticals, Inc.
    Inventors: Mark B. Anderson, Lance Christopher Christie, Quyen-Quyen Thuy Do, Jun Feng, Yufeng Hong, Haitao Li, Ved P. Pathak, Ranjan Jagath Rajapakse, Eric T. Sun, Eileen Valenzuela Tompkins